BMJ·23 SepRenal outcomes in people with type 2 diabetes with and without albuminuria treated with SGLT-2 inhibitors and GLP-1 receptor agonists: target trial emulationCohort study of 75,455 peopleSGLT2 inhibitorsPaper
ENDO 2025 Abstract·23 OctSAT-526 Trends In Diabetes Medications After Metformin In High Versus Moderate Cardiovascular Risk PatientsStudy in peoplePopulationsPaper